N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine

C69H64N18O4 — CID 135313486

IUPACN-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
SMILESCc1ccncc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.O=C(NC1CC1)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1.c1cc(-c2nccc3c(-c4ccc5cc[nH]c5c4)cc(N4CCOCC4)nc23)[nH]n1
InChIInChI=1S/C25H24N6O2.C23H20N6O.C21H20N6O/c32-25(28-18-5-6-18)17-3-1-16(2-4-17)20-15-22(31-11-13-33-14-12-31)29-23-19(20)7-9-26-24(23)21-8-10-27-30-21;1-2-16(13-20-15(1)3-6-24-20)18-14-21(29-9-11-30-12-10-29)27-22-17(18)4-7-25-23(22)19-5-8-26-28-19;1-14-2-5-22-13-17(14)16-12-19(27-8-10-28-11-9-27)25-20-15(16)3-6-23-21(20)18-4-7-24-26-18/h1-4,7-10,15,18H,5-6,11-14H2,(H,27,30)(H,28,32);1-8,13-14,24H,9-12H2,(H,26,28);2-7,12-13H,8-11H2,1H3,(H,24,26)
InChIKeyDDRIEUULBBZCRN-UHFFFAOYSA-N
MW1209.39 g/mol
LogP10.65
Rot. Bonds11

About N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine

N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine (PubChem CID 135313486) has the molecular formula C69H64N18O4 and a molecular weight of 1209.39 g/mol. Its IUPAC name is N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine.

Molecular Properties

Compound NameN-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
PubChem CID135313486
Molecular FormulaC69H64N18O4
Molecular Weight1209.39 g/mol
Exact Mass1208.54
IUPAC NameN-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
SMILESCc1ccncc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.O=C(NC1CC1)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1.c1cc(-c2nccc3c(-c4ccc5cc[nH]c5c4)cc(N4CCOCC4)nc23)[nH]n1
InChIInChI=1S/C25H24N6O2.C23H20N6O.C21H20N6O/c32-25(28-18-5-6-18)17-3-1-16(2-4-17)20-15-22(31-11-13-33-14-12-31)29-23-19(20)7-9-26-24(23)21-8-10-27-30-21;1-2-16(13-20-15(1)3-6-24-20)18-14-21(29-9-11-30-12-10-29)27-22-17(18)4-7-25-23(22)19-5-8-26-28-19;1-14-2-5-22-13-17(14)16-12-19(27-8-10-28-11-9-27)25-20-15(16)3-6-23-21(20)18-4-7-24-26-18/h1-4,7-10,15,18H,5-6,11-14H2,(H,27,30)(H,28,32);1-8,13-14,24H,9-12H2,(H,26,28);2-7,12-13H,8-11H2,1H3,(H,24,26)
InChIKeyDDRIEUULBBZCRN-UHFFFAOYSA-N
XLogP10.65
TPSA258.57 Ų
H-Bond Donors5
H-Bond Acceptors17
Rotatable Bonds11
Heavy Atoms91
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001209.39
LogP ≤ 510.65
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1017

Analyze N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
The IUPAC name of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine (CID 135313486) is N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine.
What is the SMILES notation for N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
The canonical SMILES for N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine is Cc1ccncc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.O=C(NC1CC1)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1.c1cc(-c2nccc3c(-c4ccc5cc[nH]c5c4)cc(N4CCOCC4)nc23)[nH]n1.
What is the InChIKey of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
The InChIKey is DDRIEUULBBZCRN-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24N6O2.C23H20N6O.C21H20N6O/c32-25(28-18-5-6-18)17-3-1-16(2-4-17)20-15-22(31-11-13-33-14-12-31)29-23-19(20)7-9-26-24(23)21-8-10-27-30-21;1-2-16(13-20-15(1)3-6-24-20)18-14-21(29-9-11-30-12-10-29)27-22-17(18)4-7-25-23(22)19-5-8-26-28-19;1-14-2-5-22-13-17(14)16-12-19(27-8-10-28-11-9-27)25-20-15(16)3-6-23-21(20)18-4-7-24-26-18/h1-4,7-10,15,18H,5-6,11-14H2,(H,27,30)(H,28,32);1-8,13-14,24H,9-12H2,(H,26,28);2-7,12-13H,8-11H2,1H3,(H,24,26).
What are the key properties of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine has a molecular weight of 1209.39 g/mol, XLogP of 10.65, 11 rotatable bonds, 5 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(1H-indol-6-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine is sourced from PubChem (CID 135313486), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).